Testing recovery community centers for people on medication for opioid use disorder
Part of Mental health clinical trials.
This study tests whether recovery community centers (RCCs) help people who are taking medication for opioid use disorder (MOUD) stay in recovery. If you are on MOUD and live near a center that serves a Black community, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- 18 years old or older
- Currently taking medication for opioid use disorder (like methadone, buprenorphine, or naltrexone)
- Get your medication from a clinic or pharmacy within 15 miles of a recovery community center that serves a Black community
- Willing to complete online surveys and interviews about your recovery
- Willing to be randomly assigned to one of two groups
- Have not visited a recovery community center in the last 3 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a program meant to improve treatment access and support recovery for people with opioid use disorder who also have mental health symptoms. It may help if you are new to the program or recently relapsed, or if mental health symptoms have worsened—even without a relapse.
This study tests whether adding a recovery-focused support program can improve recovery outcomes while you’re already receiving buprenorphine for opioid use disorder. It’s designed for people receiving buprenorphine as outpatient care in Massachusetts General Hospital programs.
This trial tests a peer recovery support program for people starting inpatient treatment for opioid use disorder. It aims to help you stay on medication for opioid use disorder and build a strong recovery.
This trial is focused on people who are currently getting treatment for substance use disorder. It aims to test community partnership approaches that reduce barriers and improve support during recovery.
This study tests whether extra support in community settings (like mobile units or outreach) helps people who are starting buprenorphine for opioid use disorder stay on treatment. It focuses on helping you continue your medication and stay healthy.
This study tests whether tracking your progress with regular check-ins (measurement-based care) helps improve treatment for people starting medication for opioid use disorder at a treatment program.
Hear when a new Opioid Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.